Treg-mediated suppression was measured as previously described 37 (link). Briefly, CD4+CD25+ Tregs were isolated by negative selection of CD4+ T cells, followed by positive selection of CD25+ cells using the EasySep Treg isolation kit (STEMCELL). Treg frequency was previously confirmed by flow cytometry with approximately 85% of enriched CD4+CD25+ expressing FoxP3 38 . CD4+CD25Neg effector T cells were labeled with CellTrace Violet (Invitrogen) according to manufacturer’s instructions prior to stimulation with anti-CD3 mAb (1μg/ml; 145–2C11, BioLegend) in the presence of irradiated syngeneic APC to allow for fluorescent monitoring of cell proliferation. Proliferating cells were co-cultured with varying ratios of converted CD4+CD25+ Treg from WT or TNFΔARE/+ which had been transduced with either miRZIP000 or miRZIP106a to determine the impact of selective inhibition of miR-106a on Treg suppressive function. Anti-IL-10R (10μg/ml; 1B1.3a, BioLegend) or recombinant IL-10 (10ng/ml; Peprotech, Rocky Hill, NJ) were added to culture conditions as indicated.